Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Acepodia Announces First Patient Dosed in Phase 1 Clinical Trial of ACE1831, an Anti-CD20 Armed Allogeneic Gamma Delta T-cell Therapy in Development to Treat Patients with Non-Hodgkin's Lymphoma 2023-05-23 00:00
HanX Biopharmaceuticals announces HX009 IND approval from FDA 2023-05-22 22:00
WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations 2023-05-22 16:30
Xinhua Silk Road: Conference held to foster digital, AI-driven life and health industry development in Wuxi, E. China 2023-05-22 16:06
Laekna announces first IND clearance by U.S. FDA for internally-discovered LAE102 2023-05-21 22:23
EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter 2023-05-20 04:05
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' 2023-05-20 00:55
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial 2023-05-19 21:00
Health In Tech Partners with Health Direct Partners to provide self-funded employer groups with full plan transparency, savings, and improved employee health. 2023-05-19 20:30
2023 Qingdao∙ Global Venture Capital Conference Comes to a Close 2023-05-19 20:00
Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023 2023-05-19 20:00
The 133rd Canton Fair Gathers Top Medical Equipment to Unlock the Health Code 2023-05-19 19:49
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease 2023-05-19 19:00
ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™) 2023-05-19 16:34
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics 2023-05-18 21:30
Neurophet receives FDA 510(k) Clearance for Neurophet AQUA 2023-05-18 21:00
CARsgen Initiates Phase 2 Clinical Trial for CLDN18.2 CAR T-cell Product CT041 in the U.S. 2023-05-18 20:50
Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer 2023-05-18 16:00
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031 2023-05-18 02:47
United Imaging Unveils a Full Portfolio of Products at CMEF 2023, Highlighting Its AI Capabilities across Modalities 2023-05-17 20:00
1 97 98 99 100 101 800